Ligand Pharmaceuticals | Beneficio Operativo



Operating Profit Cambio Fecha
Amgen USD 2.66B 1.37B 2025-06
Arrowhead Research USD -165550000 546.75M 2025-06
Baxter International USD 272M 214M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
Glaxosmithkline GBP 702M 513M 2024-12
Insmed USD -253876000 5.74M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
Ligand Pharmaceuticals USD 43.56M 79.78M 2025-06
MacroGenics USD -16587000 70.78M 2024-12
Merck USD 6.36B 494M 2025-06
Pacira USD 10.23M 8.24M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Veracyte USD 14.31M 13.15M 2025-06


Ligand Pharmaceuticals Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.